StockData
ProQR Therapeutics N.V. logo

ProQR Therapeutics N.V. (PRQR) stock

PRQRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 12, 2026Score 7/30
$1.10−0.05 (-4.35%)

Close on Nov 18, 2026Market cap $115.90MP/E –Yield –

ProQR Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

ProQR Therapeutics's price to sales ratio was 6.6× on Nov 11, 2026, against 13.5× a year earlier. Over the last 5 years it ranged from 5.6× to 79.3×, with a median of 16.6×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20266.6×−5.0
2025Dec 31, 202511.5×−0.2
2024Dec 31, 202411.7×−24.0
2023Dec 29, 202335.7×−43.5
2022Dec 30, 202279.3×–

More ProQR Therapeutics figures

See a number that looks wrong?